HCRS logo

Contract Research Organisation

The CRO of the HCRS provides high quality services in Cardiovascular & Medical Research. The advantage of the Cardiology focus is the establishment of a network, in Greece, of more than 70 Investigators who are selected on the basis of their expertise in the field of cardiology & academic qualifications, but also their extensive experience in clinical trials, covering geographically the entirety of the Greek territory. Being able to provide access to recognised key opinion leaders from around the global, HCRS helps to optimise the recruitment strategies of Clients. This provides the sponsor maximum efficiency in the trial preparation phase and a motivated team of Investigators who conduct clinical research studies such as:

  • Pharmaceutical
  • Post-Marketing Surveillance
  • Epidemiological
  • Devices
  • Investigator Initiated
  • Health Economics

A non-exhaustive list of cardiovascular indications that the HCRS has successfully been involved is the following:

  • Acute coronary syndromes
  • Coronary artery disease
  • Stroke
  • Atherosclerosis
  • Arrhythmias
  • Hypertension
  • Heart failure
  • Metabolic disorders
  • Pulmonary diseases

The involvement in Clinical Trials in metabolic and pulmonary diseases such as diabetes, dyslipidaemia, obesity, COPD, pulmonary hypertension, etc., is also included in the working field of the HCRS.

If you are an investigator or a sponsor and you are interested in participating or developing an HCRS Clinical Research program, please contact the CRO Manager, Ms. Maria Grammatikou, at +30 210 6723827 or by e-mail at cro@cardioresearch.net.


Go to top Top of page



Hot Articles

  1. Williams B, Cockcroft JR, Kario K et al. Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER Study
    Hypertension. 2017;69:411-420. … more More
  2. Aro AL, Rusinaru C, Uy-Evanado A et al. Syncope and risk of sudden cardiac arrest in coronary artery disease. Int. J. Cardiol. 2017; 231:26-30 … more More
  3. Raaijmakers A, Zhang ZY, Claessens J et al. Does Extremely Low Birth Weight Predispose to Low-Renin Hypertension? Hypertension. 2017; 69:443-449. … more More
  4. McCord J, Cabrera R, Lindahl B et al for the TRAPID-AMI Investigators. Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the Emergency Department.
    Circ Cardiovasc Qual Outcomes. 2017;10:e003101. … more More
  5. Aisu H, Saito M, Inaba S et al. Association of worsening arterial stiffness with incident heart failure in asymptomatic patients with cardiovascular risk factors. Hypertens Res 2017 40: 173-180 … more More
  6. Galløe AM, Kelbæk H, Thuesen L et al. 10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents. JACC 2017;69:616-624 … more More
  7. Nielles-Vallespin, S., Khalique, Z., et al. Assessment of Myocardial Microstructural Dynamics by In Vivo Diffusion Tensor Cardiac Magnetic Resonance JACC 2017;69:661-676 … more More
  8. Yeh, R. W., Silber, S., et al. 5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent: The RESOLUTE Global Clinical Trial Program . JACC:Cardiov. Interv. 2017;10:247-254 … more More
  9. Rezkalla, S. H., Stankowski, R. V., et al. Management of No-Reflow Phenomenon in the Catheterization Laboratory. JACC:Cardiov. Interv. 2017;10:215-223 … more More
  10. Mahabadi, A. A., Möhlenkamp, S., et al. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    JACC: Cardiov. Imag. 2017;10:143-153 … more More

Sign up for our newsletter: